Glycopyrrolate; Indacaterol Maleate Patent Expiration

Glycopyrrolate; Indacaterol Maleate is Used for managing airflow obstruction in patients with COPD. It was first introduced by Novartis Pharmaceuticals Corp in its drug Utibron on Oct 29, 2015.


Glycopyrrolate; Indacaterol Maleate Patents

Given below is the list of patents protecting Glycopyrrolate; Indacaterol Maleate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Utibron US6521260 Carrier particles for use in dry powder inhalers Jan 31, 2016

(Expired)

Novartis
Utibron US6582678 Carrier particles for use in dry powder inhalers Apr 24, 2018

(Expired)

Novartis
Utibron US6878721 Beta2-adrenoceptor agonists Feb 25, 2025 Novartis
Utibron US7229607 Treatment of respiratory disease Apr 09, 2021

(Expired)

Novartis
Utibron US7736670 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Utibron US7820694 Beta-2-adrenoreceptor agonists Jun 02, 2020

(Expired)

Novartis
Utibron US8029768 Treatment of respiratory diseases Apr 09, 2021

(Expired)

Novartis
Utibron US8048451 Pharmaceutical compositions for inhalation Jun 27, 2021

(Expired)

Novartis
Utibron US8067437 Beta-2-adrenoreceptor agonists Jun 02, 2020

(Expired)

Novartis
Utibron US8182838 Dry powder composition comprising co-jet milled particles for pulmonary inhalation Oct 20, 2028 Novartis
Utibron US8283362 Beta-2-adrenoreceptor agonists Jun 02, 2020

(Expired)

Novartis
Utibron US8303991 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Utibron US8435567 Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation Jun 27, 2021

(Expired)

Novartis
Utibron US8479730 Inhaler device Oct 11, 2028 Novartis
Utibron US8580306 Particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Utibron US8658673 BETA2-adrenoreceptor agonists Jun 02, 2020

(Expired)

Novartis
Utibron US8796307 Beta2-adrenoreceptor agonists Jun 02, 2020

(Expired)

Novartis
Utibron US8956661 Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof Jun 27, 2021

(Expired)

Novartis
Utibron US9931304 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis
Utibron US9962338 Method of making particles for use in a pharmaceutical composition Jun 27, 2021

(Expired)

Novartis


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳